跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,929 条关于
“muscarinic-M1-cholinergic receptors”
全部
5,929
临床试验
3,684
药物
664
机构
7
资讯
1,574
去年
Tonix Pharmaceuticals Submits NDA for TNX-102 SL in Fibromyalgia
去年
Tonix Pharmaceuticals' TNX-102 SL Shows Promise in Fibromyalgia Treatment
去年
Tonix Pharmaceuticals Submits NDA for TNX-102 SL for Fibromyalgia Treatment
去年
First Patient Dosed in Phase 2 OASIS Trial of TNX-102 SL for Acute Stress Reaction Following Trauma
去年
FDA Approves Cobenfy, a Novel Schizophrenia Treatment Targeting Cholinergic Receptors
去年
FDA Approves Cobenfy, a Novel Muscarinic Receptor-Targeting Drug for Schizophrenia
去年
Schizophrenia Treatment Targeting Cholinergic Receptors Receives FDA Approval
2年前
Tonix Pharmaceuticals' Tonmya™ Receives Conditional FDA Acceptance for Fibromyalgia Treatment
去年
Xanomeline/Trospium Chloride (COBENFY™) Approved for Schizophrenia Treatment
去年
MapLight Therapeutics Initiates Phase 2 Trial of Novel M1/M4 Muscarinic Agonist ML-007C-MA for Schizophrenia Treatment
第 1 页，共 158 页
上一页
下一页
